Olaplex (NASDAQ:OLPX - Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, March 6th. Analysts expect Olaplex to post earnings of $0.02 per share and revenue of $87.51 million for the quarter. Individual that wish to listen to the company's earnings conference call can do so using this link.
Olaplex Stock Performance
Olaplex stock remained flat at $1.45 during mid-day trading on Friday. 1,768,568 shares of the company's stock were exchanged, compared to its average volume of 1,239,022. The company has a fifty day moving average of $1.56 and a two-hundred day moving average of $1.91. The firm has a market cap of $961.24 million, a P/E ratio of 24.17 and a beta of 2.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 10.32 and a current ratio of 11.84. Olaplex has a 1 year low of $1.19 and a 1 year high of $2.77.
Analyst Ratings Changes
OLPX has been the topic of a number of research reports. Barclays reduced their price objective on Olaplex from $2.00 to $1.50 and set an "equal weight" rating on the stock in a research report on Monday, November 11th. Telsey Advisory Group restated a "market perform" rating and set a $2.00 price target on shares of Olaplex in a report on Tuesday, February 25th. Finally, Piper Sandler raised their price objective on shares of Olaplex from $1.50 to $2.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Olaplex has an average rating of "Hold" and a consensus target price of $2.10.
View Our Latest Report on OLPX
Olaplex Company Profile
(
Get Free Report)
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Featured Stories

Before you consider Olaplex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olaplex wasn't on the list.
While Olaplex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.